Skip to main content
International
Ask us anything:
  • About
        • About We challenge convention so healthy can be possible
        • Our Story
          • Amneal at-a-glance
          • Our Founders
          • Our Milestones
        • Our Purpose & Commitments
        • Our Culture
          • Rise, Lead, Succeed
        • Our Leadership
          • Executive Leadership
          • Board of Directors
        • Our Locations
        • Responsibility
          • The Amneal Patient Assistance Programs
          • Product Donations
          • National & Local Philanthropy
          • Compliance and Ethics
        • Patient Community Connections
          • Our Commitment to Parkinson's
        • Awards & Recognition
  • Products
        • Products We create essential medicines
        • Our Portfolio
          • Biosciences
          • Generic Products
          • Specialty Products
          • Product Catalog
        • Quality
        • Drug Safety
          • Adverse Event Reporting
          • Medical Inquiries
          • Product Complaints
        • Operations
  • Research & Development
        • Research & Development We invest significantly in new product development
        • Generics R&D
        • Specialty R&D
          • Drug Delivery Technologies
        • Product Partnering
  • Investors
        • Investors Become an Informed Investor
  • News
  • Careers
        • Careers Help make healthy possible
        • Total Rewards
        • Search Our Career Opportunities
  • Contact
  • Customer Login
Amneal Pharmaceuticals
  • Investor Relations
  • Financial Reports
    • SEC Filings
    • Annual Reports
    • Quarterly & Other Reports
  • Events & Presentations
  • Stock Information
  • Corporate Governance
    • Policies
    • Executive Officers & Directors
    • Board Committees
  • Investor Resources
    • Analysts
    • Investor FAQ
    • Email Alerts
    • Information Request
    • RSS Feeds

Home Home  >  News  >  Press Releases

  • Investor Relations
  • Financial Reports
    • SEC Filings
    • Annual Reports
    • Quarterly & Other Reports
  • Events & Presentations
  • Stock Information
  • Corporate Governance
    • Policies
    • Executive Officers & Directors
    • Board Committees
  • Investor Resources
    • Analysts
    • Investor FAQ
    • Email Alerts
    • Information Request
    • RSS Feeds
Normal
Press Release RSS Feed (opens in new window)
Press release year list 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002
Dec 31, 2008
Impax Sued Based on Anda For Generic Doryx
Dec 15, 2008
Robert L. Burr Elected Chairman of the Board of Directors of IMPAX Laboratories, Inc.
Dec 11, 2008
Impax Provides Update On Meeting With FDA To Review Phase III Trial Results For IPX056
Dec 09, 2008
Impax’s Registration Statement on Form 10 Becomes Effective
Dec 08, 2008
Amneal Receives FDA Approval For Over-The-Counter Strength Naproxen Sodium Tablets & Caplets, USP
PDF format download (opens in new window)
Dec 03, 2008
IMPAX Files Amended Form 10/A Registration Statement
Dec 01, 2008
Medicis and IMPAX Announce R&D Collaboration and Settlement
Nov 28, 2008
Impax Receives Final Fda Approval For Generic Wellbutrin® Xl 150 Mg
Nov 18, 2008
Impax Sued Based on Anda for Generic Cymbalta®
Nov 14, 2008
Impax To Webcast Presentation To Analysts On November 17, 2008
Oct 10, 2008
Impax Files Form 10 Registration Statement
PDF format download (opens in new window)
Sep 18, 2008
IMPAX To Present At UBS 2008 Global Life Sciences Conference
Sep 15, 2008
IMPAX Mourns The Death Of Dr. Charles Hsiao, Co-Founder And Chairman
Sep 08, 2008
Amneal Receives FDA Approval For Its First Liquid Rx Product, Ranitidine Hydrochloride Syrup
PDF format download (opens in new window)
Aug 13, 2008
IMPAX Sued Based on ANDA for Generic Ultram® ER
Aug 07, 2008
IMPAX Reports Positive Results in Phase III Trial with IPX056
Jul 31, 2008
Impax to Present at Bank Of America Specialty Pharmaceuticals Conference
Jul 28, 2008
Impax Sued Based On Anda Amendment For Additional Dosage Forms Of Generic OPANA® ER
Jul 22, 2008
IMPAX Sued Based on ANDA for Generic Flomax ®
Jul 16, 2008
IMPAX Announces Final Settlement Of Generic EFFEXOR XR Patent Suit
Jun 28, 2008
Amneal Closes Purchase of Interpharm Assets
PDF format download (opens in new window)
Jun 27, 2008
IMPAX Updates the Filing Status of Its Registration Statement
May 28, 2008
IMPAX Cancels Scheduled Presentation at UBS Global Specialty Generic Pharmaceuticals Conference
May 27, 2008
IMPAX Reports on SEC Order Revoking Common Stock Registration and Progress in Obtaining Re-Registration
May 23, 2008
IMPAX to Present at UBS Global Specialty and Generic Pharmaceuticals Conference
May 15, 2008
IMPAX to Present at Citi Investment Research 2008 Global Healthcare Conference
May 08, 2008
IMPAX to Present at Bank of America's 2008 Healthcare Conference
May 07, 2008
Amneal Receives FDA Approval Using New Electronic Filing Format
PDF format download (opens in new window)
May 02, 2008
IMPAX Continues to Make Progress in Filing Delinquent Periodic Reports
Apr 24, 2008
Amneal to Acquire Assets of Interpharm Holdings
PDF format download (opens in new window)
Apr 17, 2008
IMPAX Reports FDA Finding That Budeprion XL(R) 300 mg Is Safe and Effective
Apr 14, 2008
IMPAX to Develop Next-Generation Carbidopa/Levodopa Product
Mar 31, 2008
Demeclocycline HCl Tabs Approved
PDF format download (opens in new window)
Mar 31, 2008
IMPAX Establishes Branded Products Division with Appointments of Senior Management
Mar 11, 2008
IMPAX To Present at Upcoming Investment Conferences
Mar 07, 2008
Primidone Tabs Approved
PDF format download (opens in new window)
Mar 06, 2008
IMPAX Comments on Lawsuit Related to Generic Version of Detrol LA(R)
Mar 01, 2008
Cyclobenzaprine HCl Tabs Approved
PDF format download (opens in new window)
Feb 27, 2008
IMPAX to Present Oral Argument in SEC Proceeding on May 5th
Feb 01, 2008
IMPAX to Present at Merrill Lynch's Global Pharmaceutical, Biotechnology and Medical Device Conference
Jan 30, 2008
IMPAX Receives FDA Non-Approvable Letter for Vadova(R); Company Considering Options
Jan 15, 2008
IMPAX Announces Lawsuit Related to Generic Version of SOLODYN(R)
Jan 03, 2008
IMPAX to Present at JP Morgan's 26th Annual Healthcare Conference

Investor Faq

Get answers to important investor relation questions.

More

Investor Tools

  • Email Alerts
  • RSS Feeds
  • Email Page

IR Contact

Get answers to your investor relation questions.

More
  • Privacy Policy
  • Copyright & Legal Disclaimer
  • Web Accessibility
© Amneal Pharmaceuticals LLC.
All rights reserved.
Powered By Q4 Inc. 5.86.0.1 (opens in new window)
Back to top